Returning to basic principles to develop more effective treatments for central nervous system disorders.

Authors:
Wexler BE.

Journal:
Exp Biol Med (Maywood)

Publication Year: 2022

DOI:
10.1177/15353702221078291

PMCID:
PMC9158240

PMID:
35172621

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Exp Biol Med (Maywood)

Abbreviation: Exp Biol Med (Maywood)

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Physiology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A phase 1 trial of human telomerase reverse transcriptase (hTERT) vaccination combined with therape…
Zareian N; Eremin O; Pandha H and 13 more (2024) - Transparency Score: 4/6
A robust class decomposition-based approach for detecting Alzheimer's progression.
Alwuthaynani MM; Abdallah ZS; Santos-Rodriguez R. (2023) - Transparency Score: 3/6
Oral microbiota in human health and disease: A perspective.
Santacroce L; Passarelli PC; Azzolino D and 7 more (2023) - Transparency Score: 3/6
Predictive value of serum HIF-1α and VEGF for arrhythmia in acute coronary syndrome patients.
Li B; Feng Q; Yu C and 7 more (2023) - Transparency Score: 3/6
Antiviral activity of medicinal plant-derived products against SARS-CoV-2.
de Oliveira JR; Antunes BS; do Nascimento GO and 5 more (2022) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of conflicting interests: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Professor Wexler and Yale University hold equity in the Yale Start-Up company C8Sciences which sells and supports use of Digital Neurotherapy interventions based on Professor Wexler’s research at Yale. If C8Sciences becomes profitable, Professor Wexler and Yale University could benefit financially."

Evidence found in paper:

"Funding: The author(s) received no financial support for the research, authorship, and/or publication of this article."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025